Zacks.com on MSN2h
Regeneron Gets Positive CHMP Opinion for Multiple Myeloma DrugThe CHMP recommends conditional marketing authorization of REGN's linvoseltamab to treat adults with relapsed and refractory multiple myeloma.
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
"Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP" was originally created and published by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback